Zimmer Biomet Holdings, Inc. Reports Fourth Quarter and Full-Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Needham & Company Raised Price Target on Zimmer Biomet Holdings (ZBH) Following Mixed 4Q Results
January 28, 2016 1:25 PM ESTNeedham & Company reiterated a Buy rating on Zimmer Holdings (NYSE: ZBH), and raised the price target to $129.00 (from $127.00), following the company's 4Q earnings report. Revenue was $1.934B, missing consensus estimates of $1.954B. And EPS was $2.09, beating out the consensus of $2.04.
Analyst Mike Matson... More
Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c
January 28, 2016 7:36 AM ESTZimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.09, $0.05 better than the analyst estimate of $2.04. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2016 EPS of $7.80-$7.95, versus the... More
